---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-041440"
form_type: "8-K"
ticker: "NGNE"
cik: "0001404644"
company_name: "Neurogene Inc."
filed_at: "2024-02-21T23:59:59+00:00"
generated_at: "2026-06-05T21:53:05.983957+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Neurogene appoints Donna Cochener as SVP and General Counsel

## Summary
- Donna Cochener appointed SVP, General Counsel effective February 15, 2024.
- Base salary set at $370,000 annually; eligible for annual bonus up to 35% of salary.
- Received option grant for 40,000 shares; 25% vests at one year, rest monthly over 36 months.
- Prior consulting agreement terminated upon hire; no written employment agreement.

## SEC filing metadata
- accession: 0001193125-24-041440
- form_type: 8-K
- ticker: NGNE
- cik: 0001404644
- company_name: Neurogene Inc.
- filed_at: 2024-02-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404644/000119312524041440/0001193125-24-041440-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404644/000119312524041440/d699526d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-041440
- JSON: https://secwatch.observer/filing/0001193125-24-041440.json
- Plain text: https://secwatch.observer/filing/0001193125-24-041440.txt

## Key facts
- Executive change
  Donna Cochener was appointed as Senior Vice President, General Counsel at Neurogene Inc..
  - Action: appointed
  - Role: Senior Vice President, General Counsel
  source text: On February 15, 2024, Neurogene Inc. (the “Company”) appointed Donna Cochener as Senior Vice President, General Counsel.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1404644/000119312524041440/0001193125-24-041440-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.